Table 1.

Proportion of iNKT cells in respective MNC populations at the time of boosting injection




Liver MNCs, %

Spleen MNCs, %
Vehicle primed   22.7 ± 4.4   1.7 ± 0.8  
α-GalCer primed   24.5 ± 3.4   3.3 ± 1.8  
OCH primed
 
23.6 ± 5.1
 
2.5 ± 1.5
 



Liver MNCs, %

Spleen MNCs, %
Vehicle primed   22.7 ± 4.4   1.7 ± 0.8  
α-GalCer primed   24.5 ± 3.4   3.3 ± 1.8  
OCH primed
 
23.6 ± 5.1
 
2.5 ± 1.5
 
Close Modal

or Create an Account

Close Modal
Close Modal